Invivyd (IVVD) Selling, General & Administrative (2021 - 2026)

Invivyd (IVVD) Selling, General & Administrative (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.13 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 110.21 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 593.21 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 2,715.95
7 Royalty Pharma 33.72 Bn 35.84 Bn - 161.89 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 347.92 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 247.47 Mn
10 Invivyd 212.23 Mn 52.15 Mn 13.01 Mn 29.47 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 29.47 Mn
Dec 31, 2025 18.57 Mn
Sep 30, 2025 15.02 Mn
Jun 30, 2025 16.59 Mn
Mar 31, 2025 16.75 Mn
Dec 31, 2024 14.42 Mn
Sep 30, 2024 12.96 Mn
Jun 30, 2024 21.09 Mn
Mar 31, 2024 14.93 Mn
Dec 31, 2023 15.09 Mn
Sep 30, 2023 12.89 Mn
Jun 30, 2023 10.11 Mn
Mar 31, 2023 11.05 Mn
Dec 31, 2022 10.52 Mn
Sep 30, 2022 13.20 Mn
Jun 30, 2022 14.62 Mn
Mar 31, 2022 8.70 Mn
Dec 31, 2021 14.66 Mn
Sep 30, 2021 11.05 Mn
Jun 30, 2021 7.12 Mn